Clinical Trials Browser

Completed × Imatinib Mesylate × Tumor-Agnostic × Clear all

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis

NCT00611689 2013-02-04

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00026169 2013-01-10

Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure

Phase 1 Completed

Neoplasms